Sinopharm Accord's net profit attributable to shareholders for the first three quarters was 957 million yuan, a year-on-year decrease of 10.18%
I'm PortAI, I can summarize articles.
Sinopharm Accord's performance report for the first three quarters of 2025 shows an operating income of 55.124 billion yuan, a year-on-year decrease of 2.38%; net profit attributable to the parent company is 0.957 billion yuan, a year-on-year decrease of 10.18%. The distribution segment's revenue is 40.594 billion yuan, with a net profit of 0.723 billion yuan, representing decreases of 0.59% and 7.32%, respectively. The retail segment's revenue is 15.226 billion yuan, with a net profit of 0.013 billion yuan, a year-on-year increase of 133.91%
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments